What is DNAPrint Genomics, Inc. (DNAG) stock price today?

DNAPrint Genomics, Inc. (DNAG) is currently trading at $0.00.

What is DNAG return on equity (ROE)?

DNAPrint Genomics, Inc.'s return on equity (ROE) is 300.00%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is DNAPrint Genomics, Inc.'s market cap?

DNAPrint Genomics, Inc. has a market capitalization of $12892.

OTC · Biotechnology

DNAPrint Genomics, Inc. (DNAG) Stock

$0.00 OTC: DNAG Healthcare

DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services.

Valuation

Metric	Value
Price	$0.00
Market Cap	$12892
P/E Ratio	—
P/B Ratio	—
P/S Ratio	0.40
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	300.00%
ROA	-105.00%
ROCE	225.00%
Gross Margin	23.11%
Operating Margin	-730.55%
Net Margin	-235.64%
Debt/Equity	-1.75
Current Ratio	0.17

Annual Financials (USD)

Metric	2002	2003	2004	2005	2006
Revenue	$0	$1.0M	$1.0M	$1.0M	$2.0M
Operating Profit	$3.0M	$6.0M	$3.0M	$-5.0M	$-9.0M
Net Profit	$-3.0M	$-8.0M	$-4.0M	$-9.0M	$-12.0M
EPS	$-0.14	$-3.20	$-0.20	$-0.09	$-0.03
Op Margin	1416.2%	878.6%	424.4%	-365.5%	-364.4%

Balance Sheet (USD)

Metric	2002	2003	2004	2005	2006
Total Assets	$0	$1.0M	$2.0M	$6.0M	$10.0M
Total Liabilities	$2.0M	$3.0M	$2.0M	$10.0M	$14.0M
Cash	$0	$0	$1.0M	$2.0M	$1.0M
Borrowings	$1.0M	$1.0M	$1.0M	$1.0M	$7.0M

Cash Flow (USD)

Metric	2002	2003	2004	2005	2006
Operating Cash Flow	$-2.0M	$-2.0M	$-4.0M	$-4.0M	$-6.0M
Investing Cash Flow	$0	$0	$0	$-2.0M	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$1.0M	$1.0M	$-1.0M
Free Cash Flow	$-2.0M	$-2.0M	$-4.0M	$-4.0M	$-6.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	1.58
EV / EBITDA	-0.90
FCF Yield	-46540.49%
Quick Ratio	0.14
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.18%

Institutions Float Held0.18%

Institutional Holder	Shares	Report Date
FCA Corp /TX	1,175,300	2026-03-31
Ballast Advisors LLC	870	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AVXTAVAX Technologies, Inc.	$0.00	—	0.00	$6894	0.00%
BRAXFBraxia Scientific Corp.	$0.00	—	-0.09	$28328	0.00%
IPAHInterpharm Holdings, Inc.	$0.00	—	—	$660	0.00%
JNHMFJack Nathan Medical Corp.	$0.00	—	-0.70	$87099	0.00%
LADXLadRx Corporation	$0.01	-89.72%	0.00	$5446	0.00%

About DNAPrint Genomics, Inc.

DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.

DNAPrint Genomics, Inc. (DNAG) stock trades at $0.00 with a market capitalization of $12892. The stock is valued at price-to-sales of 0.40. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, DNAPrint Genomics, Inc. generates a return on equity (ROE) of 300.00% — well above the market average, a sign of a high-quality business, return on capital employed of 225.00%, an operating margin of -730.55%, a net profit margin of -235.64%.

Official website: www.dnaprint.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides